Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record describes a Phase 2 study of avutometinib alone versus avutometinib plus defactinib for recurrent low-grade serous ovarian cancer. It also provides participant eligibility, study locations, measured outcomes, and the status that the study is active but no longer recruiting.
    Difference
    73%
    Check dated 2026-11-09T13:48:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:47:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    An NIH-wide notice announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:44:25.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T15:45:42.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:58:06.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied message while preserving the site header and footer.
    Difference
    18%
    Check dated 2026-09-21T22:10:01.000Z thumbnail image

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.